Search

Help save lives. Get immunized.

… Friday, December 18, 2020 Memorial Sloan Kettering (MSK) Healthcare Heroes are rolling up their sleeves to receive the COVID-19 vaccine. COVID-19 vaccination is our best shot at controlling/ ending this global pandemic and helping protect our immunocompromised patients, their families, MSK staff, and

Researchers at the Sloan Kettering Institute have found that gut microbes shape the immune system of mice in an unexpected way.

… Wednesday, May 12, 2021 The immune system’s main job is identifying things that can make us sick. In the language of immunology, this means distinguishing “self” from “non-self”: The cells of our organs are self, while disease-causing bacteria and viruses are non-self. But what about the billions of

Read about a new treatment combining bispecific antibodies that is effective against extramedullary myeloma.

… Sunday, December 7, 2025 Researchers have made  great progress in the treatment of  multiple myeloma , a rare blood cancer, over the past decade. One important advance has been the emergence of a new class of drugs called bispecific antibodies, which work well in people for whom previous treatments have

Meet Ruben Escobar, an MSK security guard who values his family members, friends, and colleagues who have helped him get through life’s pivots and challenges.

… Thursday, September 23, 2021 Relationships mean everything to Ruben Escobar, a security guard at Memorial Sloan Kettering Cancer Center. He values his family members, friends, and colleagues who have helped him get through life’s pivots and challenges. “Growing up in the South Bronx, we all looked after

Updated results of a clinical trial that launched in 2007 were presented today by Ethan Basch, MD, of Memorial Sloan Kettering Cancer Center (MSK) and UNC Lineberger Comprehensive Cancer Center, at the annual meeting of the American Society of Clinical Oncology. Data showed that systematic symptom monitoring during outpatient chemotherapy using web-based patient-reported outcomes (PROs) improved overall survival.

… Sunday, June 4, 2017 Updated results of a clinical trial that launched in 2007 were presented today by Ethan Basch, MD, of Memorial Sloan Kettering Cancer Center (MSK) and UNC Lineberger Comprehensive Cancer Center, at the annual meeting of the American Society of Clinical Oncology. Data showed that

Hartford Healthcare Cancer Institute becomes first health system in the nation designated as MSK Care Partner.

… Wednesday, January 28, 2026 Memorial Sloan Kettering Cancer Center (MSK) has launched  Care Partners of Memorial Sloan Kettering Cancer Center (MSK Care Partners) - an MSK initiative of healthcare organizations that are committed to working with MSK toward a shared goal of expanding access to integrated

Learn how GSK graduate Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy.

… Friday, July 12, 2024 Ellen Horste’s job is a little bit like packing for Mars — where every efficiency and every little bit of room that can be saved matter. As a payload engineer for a gene therapy startup, Dr. Horste designs genetic elements that get loaded into a virus for delivery into the human

Learn more about five essential strategies for coping with the fear of cancer, from MSK psychiatrist Dr. Monique James.

… Thursday, November 20, 2025 There’s no doubt about it: Cancer is scary. But the fear of cancer, sometimes called “carcinophobia,” can cause significant distress. You may be afraid of developing cancer. You may have just been diagnosed. In either case, it’s important to remember that there are ongoing

In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with us for initial or ongoing cancer care.

… Wednesday, September 21, 2016 In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center (MSK) has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.

… Thursday, July 1, 2010 Summary Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute. Harold